HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Apoptotic potential of sesquiterpene lactone ergolide through the inhibition of NF-kappaB signaling pathway.

Abstract
Treatment with ergolide, a sesquiterpene lactone from Inula britannica var chinensis, caused the induction of apoptosis in Jurkat T cells, which was confirmed by DNA fragmentation, caspase-3 activation and cleavage of poly(ADP-ribose) polymerase in response to ergolide. Furthermore, mitochondrial dysfunction appeared to be associated with ergolide-induced apoptosis, because Bax translocation and cytochrome c release were stimulated by ergolide. In parallel, the nuclear factor-kappaB (NF-kappaB) signaling pathway was significantly inhibited by ergolide, which was accompanied by down-regulation of cell survival molecules, such as X-chromosome-linked inhibitor of apoptosis and Bcl-2. In addition, the JNK signaling pathway was involved in ergolide-induced apoptosis. Collectively, our results identified a new mechanism for the anti-cancer property of ergolide, attributable to the induction of apoptosis through down-regulation of cell survival signal molecules resulting from inhibition of the NF-kappaB signaling pathway.
AuthorsYong Jin Song, Dae Young Lee, Su-Nam Kim, Kang Ro Lee, Hyang Woo Lee, Jeung-Whan Han, Dong-Won Kang, Hoi Young Lee, Yong Kee Kim
JournalThe Journal of pharmacy and pharmacology (J Pharm Pharmacol) Vol. 57 Issue 12 Pg. 1591-7 (Dec 2005) ISSN: 0022-3573 [Print] England
PMID16354403 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Lactones
  • NF-kappa B
  • Sesquiterpenes
  • ergolide
  • Luciferases
Topics
  • Apoptosis (drug effects)
  • Genes, Reporter
  • HeLa Cells
  • Humans
  • Jurkat Cells
  • Lactones (pharmacology)
  • Luciferases (genetics)
  • NF-kappa B (antagonists & inhibitors, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sesquiterpenes (pharmacology)
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: